Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-11-21

FDA Approved: LINEZOLID — Supplemental Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Camber Pharmaceuticals' supplemental application for Linezolid (generic linezolid) under ANDA 211813. This action confirms approval of a generic Li…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Linezolid (Linezolid)

Snippet

SUPPL AP for LINEZOLID (LINEZOLID)